Comments on "Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study".

Beduk Esen, Caglayan Selenge; Can, Gizem Nur; Akkus Yildirim, Berna

Beduk Esen, Caglayan Selenge; Can, Gizem Nur; Akkus Yildirim, Berna.

Affiliation

Beduk Esen CS; Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey. Electronic address: selengebedk@gmail.com.
Can GN; Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
Akkus Yildirim B; Department of Radiation Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.

Radiother Oncol ; 197: 110292, 2024 08.

Article in En | MEDLINE | ID: mdl-38648993

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Propensity Score / Chemoradiotherapy / Nasopharyngeal Carcinoma / Neoplasm Staging Limits: Humans Language: En Journal: Radiother Oncol Year: 2024 Document type: Article Country of publication: Irlanda

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google